Sign in

What researchers published on Neuromyelitis optica (NMOSD)

4,497 papers, newest first.

Showing 20 of 643

  • ReviewRole of microglia in neuromyelitis optica (Review).International journal of molecular medicine
  • ReviewLatin American consensus recommendations on the role of magnetic resonance imaging in neuromyelitis optica spectrum disorder in clinical practice.Multiple sclerosis and related disorders
  • ReviewThe Balance Between Immune Activation and Tolerance in AQP4 Antibody-Positive Neuromyelitis Optica Spectrum Disorders and MOG Antibody-Associated Disease.Immunology and cell biology
  • ReviewRecognizing and Differentiating Area Postrema Syndrome Across NMOSD, MOGAD, and GFAP Astrocytopathy.International journal of molecular sciences
  • ReviewWhy repair fails in AQP4-IgG-positive neuromyelitis optica spectrum disease: an astrocyte-centered framework for remyelination and neuroaxonal preservation.Frontiers in immunology
  • Meta-analysisPrevalence of autoimmune comorbidities in aquaporin 4-immunoglobulin G positive neuromyelitis optica spectrum disorder: a systematic review and meta-analysis.Multiple sclerosis and related disorders
  • ReviewEculizumab and Ravulizumab During Pregnancy in Neuromyelitis Optica Spectrum Disorder and Myasthenia Gravis: Balancing Maternal Disease Control and Fetal Safety.CNS drugs
  • ReviewMetabolic reprogramming in neuromyelitis optica spectrum disorder: From astrocyte dysfunction to immune-mediated neuroinflammation.Multiple sclerosis and related disorders
  • ReviewUse of MRI in neuromyelitis optica spectrum disorder and myelin oligodendrocyte glycoprotein antibody-associated disease - MAGNIMS consensus recommendations.Nature reviews. Neurology
  • ReviewRecognition and management of acute relapse of multiple sclerosis, neuromyelitis optica spectrum disorder and myelin oligodendrocyte glycoprotein antibody-associated disease.Cell death and differentiation
  • Meta-analysisA systematic review and meta-analysis of the efficacy and safety of eculizumab in AQP4-IgG-positive neuromyelitis optica spectrum disorder.Multiple sclerosis and related disorders
  • ReviewMultimodal MRI biomarkers and machine learning in neuromyelitis optica spectrum disorder: a review.Frontiers in neurology
  • ReviewNeuromyelitis optica spectrum disorder overlapping with Sjögren's disease: immunopathological links and therapeutic implications.Frontiers in immunology
  • ReviewGlobal trends and emerging hotspots in neuromyelitis optica spectrum disorder diagnostic research: A bibliometric analysis.Medicine
  • ReviewDe-Escalating and Discontinuing Immunotherapies in Patients With NMOSD and MOGAD.Neurology
  • ReviewOCTA-derived retinal microvascular biomarkers in neuromyelitis optica spectrum disorder: clinical potential, methodological challenges, and possible links to astrocytopathy.Frontiers in medicine
  • ReviewIntractable hiccups as a brainstem red flag: demyelinating disorders with emphasis on neuromyelitis optica spectrum disorder and area postrema syndrome.Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology
  • ReviewUse of Fluid Biomarkers in NMOSD and MOGAD: Clinical and Research Applications.Neurology(R) neuroimmunology & neuroinflammation
  • Meta-analysisImpact of smoking on clinical outcomes in NMOSD and MOGAD: A meta-analysis.Multiple sclerosis and related disorders
  • Meta-analysisRetinal neuroaxonal degeneration in NMOSD vs. MS and unaffected controls: A systematic review and meta-analysis of OCT biomarkers.Multiple sclerosis and related disorders